ARKG
- ARK Genomic Revolution ETF基本情報
| 最早日付 | 2014-10-31 |
ETF情報
| ファンド提供者 | ARK Invest |
| インデックス | Active (No Index) |
| 経費率 | 0.75% |
| 保有銘柄数 | 42 |
| 設定日 | 2014-10-31 |
| 資産クラス | Equity |
| 上場 | US-listed |
| セクター | Healthcare |
| 投資スタイル | Growth |
| 非レバレッジ | Non-leveraged |
ARKGについて
The ARK Genomic Revolution ETF is an actively managed fund that invests in companies driving advancements in genomics, gene editing, genetic therapy, molecular diagnostics, and stem cell advances. The fund's portfolio is tilted towards smaller firms and is designed to capture long-term growth potential in the healthcare and biotechnology sectors.